Reading Jasson Urbach’s latest attack on the draft intellectual property (IP) policy (New patents policy the wrong cure for improving access to medicines, September 13) reminds us of the story of the scorpion and the frog, and that doomed river crossing. Despite the assurance that it was not in his interest to sting the frog, the scorpion just couldn’t help himself. "It’s in my nature," he shrugged as they both drowned. As a self-styled independent economist, Urbach should know better than to rely largely on the conclusions of a single, contested study. To his credit, he also throws in a red herring and a misplaced quotation from one of SA’s foremost scientists. As a director of the Free Market Foundation and head of its health policy unit, he probably couldn’t help himself. So let’s start with the single study. For those of us old enough to remember the battles around access to antiretroviral (ARV) medicines in the early 2000s, we’re pretty familiar with the work of Prof Amir Attar...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now